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Available online xxxxThe possible etiologies of orbital apex syndrome range from inﬂammatory, infectious, neoplastic, iatrogenic/trau-
matic, to vascular processes. In patientswithout obvious infection or systemic cancer history, judicious use of cor-
ticosteroids is a reasonable strategy.We describe a 64-year-old man who presented with orbital apex syndrome
and had progressed to total visual loss in three days after admission. Radiological imaging and pathological stud-
ies were consistent with a neuroendocrine tumor with multiple metastases. We recommend that a biopsy-
proven specimen is warranted in patient with orbital apex syndrome even without a cancer history.





Lesions affecting the anatomically adjacent structures, including
optic nerve (II), oculomotor nerve (III), trochlear nerve (IV), abducens
nerve (VI), ophthalmic/maxillary branch of the trigeminal nerve (V1,
V2) and oculosympathetic ﬁbers, may cause three partially overlapping
clinical syndromes: superior orbital ﬁssure, orbital apex, and cavernous
sinus syndrome. The etiologies causing these syndromes are also quite
similar, i.e., inﬂammatory, infectious, neoplastic, iatrogenic/traumatic,
or vascular processes. Based on the broad spectrumof etiologies, the de-
cision on evaluation andmanagement remains a great challenge to clin-
ical physicians [1]. For example, the use of corticosteroids is warranted
for inﬂammatory process, but may be harmful to some infection etiolo-
gies. Also, conservative measures may be adequate for some causes,
whereas urgent procedures are necessary in others.
Possible primary tumors involving the orbital apex and cavernous
sinus include lymphoma, neural tumors and local invasion from adja-
cent head and neck tumors. The metastatic tumors include the origins
frombreast, lung, kidney andmalignantmelanoma. Some inﬂammatory
causes, like orbital pseudotumor, Tolosa-Hunt syndrome, and thyroid
orbitopathy, may mimic neoplasms [1–3]. Among the neoplasms, neu-
roendocrine tumor is relatively rare and usually arises from gastrointes-
tinal tract or bronchopulmonary source [4]. Here, we reported a rare
case of high grade neuroendocrine tumor of unknown primary site
with initial presentation of progressive ptosis and vision loss as orbitalLin District, Taipei, Taiwan.
.
. This is an open access article underapex syndrome, which highlighted the importance of obtaining
biopsy-proven specimen in such patients.
2. Case report
A 64-year-old man was previously healthy and was referred to neu-
rological clinic for ptosis in the left eye. He had acute onset of ptosis,
retro-orbital soreness and mild blurred vision on the left side for one
month. There was no double vision and motor or sensory symptoms.
Therewas also no fever, rhinorrhea, nose stuffy, and tinnitus. The orbital
symptoms had progressed gradually without obvious diurnal change.
Neurologic examinations showed left ptosis, mild palpebral swelling
without erythematous change, sluggish light reﬂex and slight upper
ward gaze limitation in the left eye. The visual acuity was 6/10 in the
right eye and 6/12 in the left eye on the day of admission. The symptom
had progressed rapidly within three days that there was no light per-
ception and full dilated pupil without light reﬂex in his left eye. The lab-
oratory tests for inﬂammation and infection, including complete blood
count with differential count, erythrocyte sedimentation rate, C-
reactive protein, were normal. The serologic studies, including liver
and renal function, along with carcinoembryonic antigen and alpha-
fetoprotein, were also normal. The acetylcholine receptor antibody
was within normal range. The magnetic resonance imaging of brain re-
vealed a prominent left cavernous sinuswith increasing soft tissue com-
ponent that anteriorly extended into the orbital cavity, and
heterogeneous enhancement in the retrobulbar space. Trace enhance-
ments in the intracavernous and retrobulbar spaces were also depicted
(Fig.1). He underwent sphenoethomoidectomy, and a dark reddish
tumor was found at the opticocarotid recess. The pathology of thethe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Coronal contrast and noncontrast T1weighted images (A, B), axial contrast T1weighted image (C), and axial T2weighted image (D). These pictures showed the heterogeneous soft
tissues within the orbital apex, extending to orbital canal and cavernous sinus (arrows).
Fig. 2. The tumor tissue composed of large polygonal cells with hyperchromatic nuclei, distinct
nucleoli andmoderate pink cytoplasm (H&E stain, 400×). (For interpretation of the references
to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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distinct nucleoli andmoderate pink cytoplasm (Fig. 2), and immunoreac-
tivity to several immunohistochemical stainings, including cytokeratin,
neuron-speciﬁc enolase, synaptophysin and chromogranin A, which
were compatible with a neuroendocrine tumor. Positron emission
tomography/computed tomography (PET/CT) scan showed increased
multiple uptakes at the left orbital area, spines, rib cages and liver
(Fig.3). Echo-guided liver biopsy revealed the samehigh grademalignant
tumor with neuroendocrine differentiation. The primary site of the
tumor was unclear. The patient died six months after initial symptoms.3. Discussion
The orbital apex tumors range from benign inﬂammatory process to
high grade malignancy. Ocular symptom is the initial manifestation of
metastatic orbital tumors in up to 25% [5]. The diagnosismay be difﬁcult
in patients without history of systemic cancers. Neuroendocrine tumors
are rare among the metastatic orbital tumors, and the clinical manifes-
tation may masquerade cellulitis [2] or Graves orthopathy [3]. Further-
more, metastases are found in about 20% of the patients with
neuroendocrine tumors at the time of diagnosis [6]. Similar to our pa-
tient but with a different scenario, a patient was reported previously
with an unknown origin of neuroendocrine tumor in liver and was
found to have orbital metastasis on both sides six month later [7].
Fig. 3. Positron emission tomography with 2-deoxy-2-[ﬂuorine-18] ﬂuoro-D-glucose
integrated with computed tomography (18F-FDG PET/CT) showed intense uptake in left
retro-orbital region and paranasal sinus. The intense uptake also involved the spine, rib
cage, pelvic bones, bilateral femora and both lobes of liver.
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management options include observation, an empirical trial of cortico-
steroid, and surgical biopsy. Because the distinctions among inﬂamma-
tion, infection, and neoplasm are often difﬁcult and all may respond
initially to corticosteroids, a short period of therapeutic corticosteroid
trial has been suggested in the patients without systemic signs of infec-
tion or cancer history [1]. Because of the acute onset of symptoms withrapid progression that seemed to be more typical of an inﬂammatory
process, a trial of corticosteroid was considered and used. After
excluding the possibility of a vascular source by images and obtaining
sufﬁcient support of biopsy technique, a ﬁne needle biopsy was
considered at ﬁrst. Because of rapidly loss of vision, however,
sphenoethomoidectomywas done for the additional purpose of decom-
pression. Without the tissue proof, the strategy of corticosteroid use
may delay the diagnosis and further management in our patient.
From this experience, we recommend that a tissue proof may need
to be considered ﬁrst if the surgical risk is not high or the vision loss
or ophthalmalgia is progressing rapidly. Pathological evidence is crucial
for the diagnosis in patients with orbital apex syndrome, and an immu-
nohistochemistry studymay be helpful in identifying a neuroendocrine
origin.When the neuroendocrine tumor is conﬁrmed, further investiga-
tions of primary origin and possible systemicmetastases aremandatory.Conﬂicts of interest/disclosures
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